US equities |
MU $1,063.48 ▲+1.71% SNDK $1,709.17 ▲+2.93% NVDA $236.83 ▼-1.01% AMD $643.40 ▼-0.93% INTC $113.48 ▲+0.87% SPCX $167.84 ▼-2.38% TSLA $374.82 ▼-1.54% MRVL $281.28 ▼-2.00%
FinancialContent

Latest News about TRP/8803

Recent news which mentions TRP/8803

Tryptamine Therapeutics Advances Psilocin-Based IV Infusion To Phase 2 Clinical Trials
Tickers NEWS TYPTF
Tags Phase 2 Clinical Trial Health Care Benzinga
From Benzinga